Gilberto Lopes

发表

The Research Protocol

Gilberto Lopes, Gustavo Werutsky, Patricia Moretto, 2016 .

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Jianying Zhou, Erdem Goker, Jun Zhao, 2019, The Lancet.

Chimeric antigen receptor T cells, a savior with a high price.

Gilberto Lopes, George Nahas, 2018 .